Bello K, Mat Jusoh T, Irekeola A, Abu N, Mohd Amin N, Mustaffa N
Healthcare (Basel). 2023; 11(7).
PMID: 37046937
PMC: 10094200.
DOI: 10.3390/healthcare11071011.
Tseng T, Kuo Y, Hu T, Hung C, Wang J, Lu S
Viruses. 2022; 14(6).
PMID: 35746660
PMC: 9227936.
DOI: 10.3390/v14061189.
Wu C, Huang W, Chen C, Lu S
Biomed J. 2021; 45(5):798-805.
PMID: 34801765
PMC: 9661494.
DOI: 10.1016/j.bj.2021.11.007.
Squires K, Mayers D, Bluemling G, Kolykhalov A, Guthrie D, Reddy P
Antimicrob Agents Chemother. 2020; 64(9).
PMID: 32540975
PMC: 7449170.
DOI: 10.1128/AAC.00836-20.
Ma T, Hu T, Hung C, Wang J, Lu S, Chen C
PLoS One. 2019; 14(10):e0222221.
PMID: 31584951
PMC: 6777800.
DOI: 10.1371/journal.pone.0222221.
Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute Exacerbation.
Chen Y, Lu S, Wang J, Hung C, Hu T, Chen C
Dig Dis Sci. 2019; 64(9):2563-2569.
PMID: 30835025
DOI: 10.1007/s10620-019-05571-0.
Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants.
Gao S, Joshi S, Osiowy C, Chen Y, Coffin C, Duan Z
Virol J. 2017; 14(1):203.
PMID: 29065883
PMC: 5655973.
DOI: 10.1186/s12985-017-0870-x.
Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL.
Yao C, Hung C, Hu T, Lu S, Wang J, Lee C
Sci Rep. 2017; 7(1):1839.
PMID: 28500322
PMC: 5431802.
DOI: 10.1038/s41598-017-02010-w.
Poor 1st-year adherence to anti-osteoporotic therapy increases the risk of mortality in patients with magnetic resonance imaging-proven acute osteoporotic vertebral fractures.
Chen Y, Lin W
Patient Prefer Adherence. 2017; 11:839-843.
PMID: 28490865
PMC: 5414717.
DOI: 10.2147/PPA.S131564.
Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area.
Wu C, Hsu T, Kung F, Changchien C, Tsai C, Lu S
Sci Rep. 2017; 7(1):1212.
PMID: 28450703
PMC: 5430794.
DOI: 10.1038/s41598-017-01234-0.
Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.
Park Y, Lee S
World J Gastroenterol. 2016; 22(44):9836-9843.
PMID: 27956808
PMC: 5124989.
DOI: 10.3748/wjg.v22.i44.9836.
Molecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan.
Lin S, Toyoda H, Kumada T, Liu H
PLoS One. 2016; 11(6):e0157103.
PMID: 27280441
PMC: 4900519.
DOI: 10.1371/journal.pone.0157103.
Hepatitis B virus infection in Indonesia.
Yano Y, Utsumi T, Lusida M, Hayashi Y
World J Gastroenterol. 2015; 21(38):10714-20.
PMID: 26478663
PMC: 4600573.
DOI: 10.3748/wjg.v21.i38.10714.
Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion.
Chen C, Lu S, Lee C, Hung C, Wang J, Hu T
Hepatol Int. 2015; 8(3):365-74.
PMID: 26202639
DOI: 10.1007/s12072-014-9542-8.
A comparison of 4-year entecavir efficacy in nucleos(t)ide analog-naïve and -experienced adult Taiwanese chronic hepatitis B patients.
Chen C, Hu T, Hung C, Lu S, Wang J, Chang M
Hepatol Int. 2015; 7(3):832-43.
PMID: 26201920
DOI: 10.1007/s12072-013-9440-5.
Variations and mutations in the hepatitis B virus genome and their associations with clinical characteristics.
Yano Y, Azuma T, Hayashi Y
World J Hepatol. 2015; 7(3):583-92.
PMID: 25848482
PMC: 4381181.
DOI: 10.4254/wjh.v7.i3.583.
Recent advances in micro/nanotechnologies for global control of hepatitis B infection.
Yildiz U, Inci F, Wang S, Toy M, Tekin H, Javaid A
Biotechnol Adv. 2014; 33(1):178-190.
PMID: 25450190
PMC: 4433022.
DOI: 10.1016/j.biotechadv.2014.11.003.
High risk of hepatitis B virus reactivation in nucleos(t)ide analogue-induced hepatitis B e antigen seroconverters older than 40 years.
Kuo L, Lee C, Hung C, Wang J, Hu T, Lu S
Dig Dis Sci. 2014; 59(10):2580-7.
PMID: 24846794
DOI: 10.1007/s10620-014-3194-3.
Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.
Lee J, Kwon B, Osorio F, Pattnaik A, Lee N, Lee S
Vaccine. 2014; 32(29):3617-22.
PMID: 24814552
PMC: 4152009.
DOI: 10.1016/j.vaccine.2014.04.083.
Is there any value to hepatitis B virus genotype analysis?.
Tanwar S, Dusheiko G
Curr Gastroenterol Rep. 2011; 14(1):37-46.
PMID: 22105466
DOI: 10.1007/s11894-011-0233-5.